We are live on ! Find out more
DMK

DMK Pharmaceuticals Corporation Common Stock
DMK

Delisted

DMK was delisted on the 6th of February, 2024.

Back to rankings

41 hedge funds and large institutions have $3.81M invested in DMK Pharmaceuticals Corporation Common Stock in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

276% more call options, than puts

Call options by funds: $316K | Put options by funds: $84K

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

11% less funds holding

Funds holding: 46 → 41 (-5)

27% less capital invested

Capital invested by funds: $5.18M → $3.81M (-$1.37M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
41
Holders Change
-5
Holders Change %
-10.87%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
5
Closed
11
Calls
$316K
Puts
$84K
Net Calls
+$232K
Net Calls Change
-$962K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$293K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$70.1K
3
UBS Group
UBS Group
Switzerland
+$37.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$36.5K
5
TRCT
Tower Research Capital (TRC)
New York
+$7.47K

Top Sellers

Rank Fund Capital Flow
1
MS
Maven Securities
Jersey
-$795K
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$221K
3
VF
Virtu Financial
New York
-$31K
4
JCM
Jacobi Capital Management
Pennsylvania
-$20K
5
VCA
Verdence Capital Advisors
Maryland
-$19.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$6K +$7.47K +168 New
Bank of America
27
Bank of America
North Carolina
$5K – – –
MOS
28
MGO One Seven
Ohio
$5K – – –
PMG
29
Private Management Group
California
$5K – – –
WWM
30
Wolff Wiese Magana
California
$5K +$6.81K +153 New
FCMT
31
Founders Capital Management (Texas)
Texas
$4K +$5.07K +114 New
PS
32
Planned Solutions
California
$4K +$5.74K +129 New
FCM
33
Firestone Capital Management
Florida
$3K – – –
HCP
34
Hexagon Capital Partners
Arkansas
$3K – – –
AF
35
Allworth Financial
California
$2K – – –
TF
36
TimeScale Financial
Massachusetts
$2K – – –
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$243 – – –
MS
38
Maven Securities
Jersey
– -$795K -14,286 Closed
VF
39
Virtu Financial
New York
– -$31K -567 Closed
JCM
40
Jacobi Capital Management
Pennsylvania
– -$20K -357 Closed
Squarepoint
41
Squarepoint
New York
– -$17K -315 Closed
ARTA
42
A.R.T. Advisors
New York
– -$16K -292 Closed
Jane Street
43
Jane Street
New York
– -$16K -290 Closed
Millennium Management
44
Millennium Management
New York
– -$16 -286 Closed
JP Morgan Chase
45
JP Morgan Chase
New York
– -$10.6K -239 Closed
LPL Financial
46
LPL Financial
California
– -$9K -169 Closed
WCG
47
Weaver Consulting Group
California
– -$2K -32 Closed
CHAM
48
Clear Harbor Asset Management
Connecticut
– -$783 -14 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– +$133 +3 New
Wells Fargo
50
Wells Fargo
California
– +$133 +3 +50%
1
2
3

DMK Hedge Fund Activity: Q4 2020 in Review

41 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q4 2020, worth a combined $3.81M — down 27% from $5.18M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of DMK and 6 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 11 added.

The largest buyer was GSA Capital Partners, adding an estimated $293K. The largest seller was Maven Securities, exiting entirely with an estimated $795K sold.

  • 41 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q4 2020, down from 46 in Q3 2020.
  • Funds reported $3.81M of DMK Pharmaceuticals Corporation Common Stock stock for Q4 2020, down 27% quarter-over-quarter.
  • 6 funds opened new DMK Pharmaceuticals Corporation Common Stock positions in Q4 2020 and 11 closed out, a net change of -5 holders.
  • The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q4 2020 was GSA Capital Partners, an estimated $293K added.
  • The largest DMK Pharmaceuticals Corporation Common Stock seller in Q4 2020 was Maven Securities, an estimated $795K sold.

Based on aggregated 13F filings for Q4 2020.